Long path to MYC inhibition approaches clinical trials

被引：0
|
作者：
Villanueva, M. Teresa
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2019年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [31] Inclusion of women in cardiovascular clinical trials: A path forward
    Vogel, Birgit
    Mehran, Roxana
    CONTEMPORARY CLINICAL TRIALS, 2022, 115
  • [32] Recently targeted kinases and their inhibitors - the path to clinical trials
    Knapp, Stefan
    Sundstrom, Michael
    CURRENT OPINION IN PHARMACOLOGY, 2014, 17 : 58 - 63
  • [33] New Long Covid clinical trials
    不详
    SCIENCE, 2023, 381 (6657) : 464 - 464
  • [34] MYC degradation via AURKB inhibition: a new brake in the path to T-ALL
    Zhang, Wu
    Pear, Warren S.
    BLOOD SCIENCE, 2020, 2 (02): : 68 - 69
  • [35] Correction: Telomerase inhibition, oligonucleotides, and clinical trials
    David R Corey
    Oncogene, 2002, 21 : 6557 - 6557
  • [36] Designing Trials with Purpose: Pragmatic Clinical Trials of Nonpharmacological Approaches for Pain Management
    Gordon, Kirsha S.
    Peduzzi, Peter
    Kerns, Robert D.
    PAIN MEDICINE, 2020, 21 : S7 - S12
  • [37] Approaches for analysing quality of life data in clinical trials
    Robinson, PG
    Soe, KK
    Gelbier, S
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1146 - 1146
  • [38] Digital approaches to enhancing community engagement in clinical trials
    Tan, Rayner K. J.
    Wu, Dan
    Day, Suzanne
    Zhao, Yang
    Larson, Heidi J.
    Sylvia, Sean
    Tang, Weiming
    Tucker, Joseph D.
    NPJ DIGITAL MEDICINE, 2022, 5 (01)
  • [39] Changing approaches in cancer clinical trials: The nursing contribution
    Batchelor, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1346 - 1346
  • [40] Targeting tau: Clinical trials and novel therapeutic approaches
    VandeVrede, Lawren
    Boxer, Adam L.
    Polydoro, Manuela
    NEUROSCIENCE LETTERS, 2020, 731
12345